Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation

Hiroya Kobayashi, Ryusuke Omiya, Benjamin Sodey, Mitsuru Yanai, Kensuke Oikawa, Keisuke Sato, Shoji Kimura, Satoru Senju, Yasuharu Nishimura, Masatoshi Tateno, Esteban Celis

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: There is growing evidence that CD4+ helper T lymphocytes (HTLs) play an essential role in the induction and long-term maintenance of antitumor CTL responses. Thus, approaches to develop effective T-cell-based immunotherapy should focus in the stimulation of both CTLs and HTLs reactive against tumor-associated antigens. The present studies were performed with the purpose of identifying HTL epitopes for prostate-specific membrane antigen (PSMA) for the optimization of vaccines for prostate cancer. Experimental Design: Synthetic peptides from regions of the PSMA sequence that were predicted to serve as HTL epitopes were prepared with use of computer-based algorithms and tested for their capacity to trigger in vitro HTL responses in lymphocytes from normal volunteers. Results: Our results show that 4 peptides from PSMA were effective in eliciting HTL responses. Moreover, HTL reactive to 3 of the 4 peptides were capable of reacting with naturally processed antigen in the form of freeze/thaw lysates or apoptotic cells produced from PSMA-positive LNCaP tumor cell lines. Conclusions: Human HTLs are capable of effectively recognizing epitopes derived from PSMA. The information presented here should facilitate the design of improved vaccination strategies for prostate cancer.

Original languageEnglish (US)
Pages (from-to)5386-5393
Number of pages8
JournalClinical Cancer Research
Volume9
Issue number14
StatePublished - Nov 1 2003
Externally publishedYes

Fingerprint

T-Lymphocyte Epitopes
Helper-Inducer T-Lymphocytes
Peptides
Prostatic Neoplasms
In Vitro Techniques
human glutamate carboxypeptidase II
Neoplasm Antigens
Tumor Cell Line
Immunotherapy
Epitopes
Healthy Volunteers
Vaccination
Research Design
Vaccines
Lymphocytes
T-Lymphocytes
Antigens

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation. / Kobayashi, Hiroya; Omiya, Ryusuke; Sodey, Benjamin; Yanai, Mitsuru; Oikawa, Kensuke; Sato, Keisuke; Kimura, Shoji; Senju, Satoru; Nishimura, Yasuharu; Tateno, Masatoshi; Celis, Esteban.

In: Clinical Cancer Research, Vol. 9, No. 14, 01.11.2003, p. 5386-5393.

Research output: Contribution to journalArticle

Kobayashi, H, Omiya, R, Sodey, B, Yanai, M, Oikawa, K, Sato, K, Kimura, S, Senju, S, Nishimura, Y, Tateno, M & Celis, E 2003, 'Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation', Clinical Cancer Research, vol. 9, no. 14, pp. 5386-5393.
Kobayashi, Hiroya ; Omiya, Ryusuke ; Sodey, Benjamin ; Yanai, Mitsuru ; Oikawa, Kensuke ; Sato, Keisuke ; Kimura, Shoji ; Senju, Satoru ; Nishimura, Yasuharu ; Tateno, Masatoshi ; Celis, Esteban. / Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation. In: Clinical Cancer Research. 2003 ; Vol. 9, No. 14. pp. 5386-5393.
@article{affe7056e12b4605abf06ebcb0b516f9,
title = "Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation",
abstract = "Purpose: There is growing evidence that CD4+ helper T lymphocytes (HTLs) play an essential role in the induction and long-term maintenance of antitumor CTL responses. Thus, approaches to develop effective T-cell-based immunotherapy should focus in the stimulation of both CTLs and HTLs reactive against tumor-associated antigens. The present studies were performed with the purpose of identifying HTL epitopes for prostate-specific membrane antigen (PSMA) for the optimization of vaccines for prostate cancer. Experimental Design: Synthetic peptides from regions of the PSMA sequence that were predicted to serve as HTL epitopes were prepared with use of computer-based algorithms and tested for their capacity to trigger in vitro HTL responses in lymphocytes from normal volunteers. Results: Our results show that 4 peptides from PSMA were effective in eliciting HTL responses. Moreover, HTL reactive to 3 of the 4 peptides were capable of reacting with naturally processed antigen in the form of freeze/thaw lysates or apoptotic cells produced from PSMA-positive LNCaP tumor cell lines. Conclusions: Human HTLs are capable of effectively recognizing epitopes derived from PSMA. The information presented here should facilitate the design of improved vaccination strategies for prostate cancer.",
author = "Hiroya Kobayashi and Ryusuke Omiya and Benjamin Sodey and Mitsuru Yanai and Kensuke Oikawa and Keisuke Sato and Shoji Kimura and Satoru Senju and Yasuharu Nishimura and Masatoshi Tateno and Esteban Celis",
year = "2003",
month = "11",
day = "1",
language = "English (US)",
volume = "9",
pages = "5386--5393",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation

AU - Kobayashi, Hiroya

AU - Omiya, Ryusuke

AU - Sodey, Benjamin

AU - Yanai, Mitsuru

AU - Oikawa, Kensuke

AU - Sato, Keisuke

AU - Kimura, Shoji

AU - Senju, Satoru

AU - Nishimura, Yasuharu

AU - Tateno, Masatoshi

AU - Celis, Esteban

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Purpose: There is growing evidence that CD4+ helper T lymphocytes (HTLs) play an essential role in the induction and long-term maintenance of antitumor CTL responses. Thus, approaches to develop effective T-cell-based immunotherapy should focus in the stimulation of both CTLs and HTLs reactive against tumor-associated antigens. The present studies were performed with the purpose of identifying HTL epitopes for prostate-specific membrane antigen (PSMA) for the optimization of vaccines for prostate cancer. Experimental Design: Synthetic peptides from regions of the PSMA sequence that were predicted to serve as HTL epitopes were prepared with use of computer-based algorithms and tested for their capacity to trigger in vitro HTL responses in lymphocytes from normal volunteers. Results: Our results show that 4 peptides from PSMA were effective in eliciting HTL responses. Moreover, HTL reactive to 3 of the 4 peptides were capable of reacting with naturally processed antigen in the form of freeze/thaw lysates or apoptotic cells produced from PSMA-positive LNCaP tumor cell lines. Conclusions: Human HTLs are capable of effectively recognizing epitopes derived from PSMA. The information presented here should facilitate the design of improved vaccination strategies for prostate cancer.

AB - Purpose: There is growing evidence that CD4+ helper T lymphocytes (HTLs) play an essential role in the induction and long-term maintenance of antitumor CTL responses. Thus, approaches to develop effective T-cell-based immunotherapy should focus in the stimulation of both CTLs and HTLs reactive against tumor-associated antigens. The present studies were performed with the purpose of identifying HTL epitopes for prostate-specific membrane antigen (PSMA) for the optimization of vaccines for prostate cancer. Experimental Design: Synthetic peptides from regions of the PSMA sequence that were predicted to serve as HTL epitopes were prepared with use of computer-based algorithms and tested for their capacity to trigger in vitro HTL responses in lymphocytes from normal volunteers. Results: Our results show that 4 peptides from PSMA were effective in eliciting HTL responses. Moreover, HTL reactive to 3 of the 4 peptides were capable of reacting with naturally processed antigen in the form of freeze/thaw lysates or apoptotic cells produced from PSMA-positive LNCaP tumor cell lines. Conclusions: Human HTLs are capable of effectively recognizing epitopes derived from PSMA. The information presented here should facilitate the design of improved vaccination strategies for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=10744224291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744224291&partnerID=8YFLogxK

M3 - Article

C2 - 14614024

AN - SCOPUS:10744224291

VL - 9

SP - 5386

EP - 5393

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 14

ER -